Company: MIRA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024077
Chunk: 44

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 1
Chunk 44
---
 formatted in Inline XBRL.

    *
     
    Filed
    herewith.

    **
     
    Furnished
    herewith.

21

SIGNATURES

Pursuant
to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

    MIRA
    PHARMACEUTICALS, INC.

    Date:
    August 14, 2025
    By:
    /s/
    Erez Aminov 

    Erez
    Aminov

    Chief
    Executive Officer

    (Principal
    Executive Officer)

    Date:
    August 14, 2025
    By:
    /s/
    Alan Weichselbaum

    Alan
    Weichselbaum

    Chief
    Financial Officer, Treasurer and Secretary

    (Principal
    Financial Officer)

22